Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

Alzheimer's disease begins with a long period during which abnormal amyloid and tau proteins build up in the brain without ...

meaning the drug did not demonstrate a functional benefit in early Alzheimer’s Disease. It’s worth acknowledging, however, that the authors reported significant data (p=0.01) on the pooled treatment ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

GlobalData analysis suggests that China will lead with the highest number of prevalent cases of Alzheimer’s disease in 2033.

Several recent studies have suggested HRT is a risk factor in various conditions, notably Alzheimer's - now UK boffins have ...

While many people take supplements for brain health, the research supporting supplemental nutrients' effects on brain health ...

ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on developing precision therapies for neurodegenerative diseases, today announced the initiation of its Phase 1b ...

Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...

A groundbreaking study reveals that concussions and repetitive head injuries in sports could trigger latent viruses in the ...

Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...

Aging involves gradual functional decline across various biological systems, including impaired cellular mechanisms such as ...